Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Shares Outstanding (2017 - 2026)

Tilray Brands' (TLRY) quarterly Shares Outstanding (Entity) came in at $131.7 million in Q2 2026, up 24.15% YoY from $106.1 million in Q2 2025, and up 12.99% on a QoQ basis from $116.5 million in Q1 2026.

Tilray Brands (TLRY) Shares Outstanding (2017 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 10 years of Shares Outstanding (Entity) data on file, last reported at $131.7 million in Q2 2026.

  • Quarterly Shares Outstanding (Entity) rose 24.15% year-over-year to $131.7 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $131.7 million (up 24.15% YoY) and the FY2026 annual result came in at $131.7 million, up 24.15% from the prior year.
  • Shares Outstanding (Entity) improved to $131.7 million in Q2 2026, from $116.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $131.7 million in Q2 2026 to a low of $48.1 million in Q1 2022.
  • A 5-year average of $84.3 million and a median of $80.3 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 97.62% — and 2026, when it climbed 18.52%.
  • Tracing TLRY's Shares Outstanding (Entity) over 5 years: stood at $61.3 million in 2022, then advanced by 19.53% to $73.3 million in 2023, then grew by 26.79% to $92.9 million in 2024, then rose by 25.39% to $116.5 million in 2025, then gained by 13.01% to $131.7 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $131.7 million (Q2 2026), $116.5 million (Q1 2026), and $116.5 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 832.44 Mn
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn 111.83 Mn

Historic Data

Download Data
DateValue
May 31, 2026 111.83 Mn
Feb 28, 2026 112.68 Mn
Nov 30, 2025 110.34 Mn
Aug 31, 2025 106.03 Mn
May 31, 2025 89.03 Mn
Feb 28, 2025 90.83 Mn
Nov 30, 2024 86.50 Mn
Aug 31, 2024 87.54 Mn
May 31, 2024 74.26 Mn
Feb 29, 2024 75.44 Mn
Nov 30, 2023 73.08 Mn
Aug 31, 2023 69.12 Mn
May 31, 2023 61.80 Mn
Feb 28, 2023 61.55 Mn
Nov 30, 2022 61.17 Mn
Aug 31, 2022 57.53 Mn
May 31, 2022 48.12 Mn
Feb 28, 2022 48.57 Mn
Nov 30, 2021 46.03 Mn
Aug 31, 2021 44.94 Mn